HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Kitamura Selected Research

AG-041R

2/2003AG-041R stimulates cartilage matrix synthesis without promoting terminal differentiation in rat articular chondrocytes.
4/2001AG-041R, a novel indoline-2-one derivative, induces systemic cartilage hyperplasia in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Kitamura Research Topics

Disease

13Neoplasms (Cancer)
11/2017 - 01/2000
5Hyperplasia
01/2014 - 09/2000
5Inflammation (Inflammations)
06/2009 - 09/2000
4Neoplasm Metastasis (Metastasis)
12/2016 - 01/2000
4Glomerulonephritis
06/2009 - 10/2000
4Prostatic Neoplasms (Prostate Cancer)
01/2006 - 05/2000
4Adenocarcinoma of Lung
05/2004 - 09/2000
3Thrombocytopenia (Thrombopenia)
12/2014 - 06/2001
3Hypertension (High Blood Pressure)
01/2014 - 03/2001
3Proteinuria
06/2009 - 08/2001
2Breast Neoplasms (Breast Cancer)
11/2017 - 03/2001
2Carcinoma (Carcinomatosis)
12/2016 - 01/2001
2Pathologic Constriction (Stenosis)
12/2014 - 01/2014
2Urinary Bladder Neoplasms (Bladder Cancer)
06/2014 - 04/2001
2Infections
01/2014 - 05/2001
2Hypersensitivity (Allergy)
06/2009 - 10/2002
2Nephritis
06/2009 - 08/2001
2Pneumoperitoneum
05/2002 - 09/2001
2Renal Cell Carcinoma (Grawitz Tumor)
03/2002 - 01/2000
2Disseminated Intravascular Coagulation
12/2001 - 11/2000
2Colorectal Neoplasms (Colorectal Cancer)
11/2001 - 05/2000
2Lymphatic Metastasis
11/2001 - 10/2001
2Fibrosis (Cirrhosis)
08/2001 - 02/2001
2Thrombotic Microangiopathies
06/2001 - 06/2001
2Renal Insufficiency (Renal Failure)
06/2001 - 01/2001
2Necrosis
01/2001 - 10/2000
1Carcinogenesis
11/2017
1Hyperbilirubinemia
12/2014
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
12/2014
1Atopic Dermatitis (Atopic Eczema)
11/2014
1Dermatitis
11/2014
1Pruritus (Itching)
11/2014
1Eczema
11/2014
1Residual Neoplasm
06/2014
1Viremia
01/2014
1Hyper-IgM Immunodeficiency Syndrome (Hyper-IgM Syndrome)
07/2010
1Lupus Nephritis
07/2010
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2010
1Peritonitis
03/2010
1Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
06/2009
1Streptococcal Infections (Streptococcal Infection)
06/2009
1Testicular Neoplasms (Testicular Cancer)
04/2009

Drug/Important Bio-Agent (IBA)

3CytokinesIBA
11/2014 - 01/2000
3Complement System Proteins (Complement)IBA
07/2010 - 10/2000
3AntigensIBA
06/2009 - 01/2000
3Proteins (Proteins, Gene)FDA Link
05/2004 - 02/2001
3alpha-galactosylceramideIBA
07/2000 - 01/2000
2Therapeutic UsesIBA
11/2014 - 01/2000
2Tacrolimus (Prograf)FDA LinkGeneric
01/2014 - 09/2008
2Immunoglobulin M (IgM)IBA
07/2010 - 12/2001
2CollagenIBA
11/2005 - 10/2002
2Hormones (Hormone)IBA
01/2005 - 05/2000
2EnzymesIBA
01/2005 - 08/2001
2AG-041RIBA
02/2003 - 04/2001
2Carbon DioxideIBA
05/2002 - 09/2001
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2002 - 08/2001
2Glucose (Dextrose)FDA LinkGeneric
01/2002 - 10/2001
2Dacarbazine (DIC)FDA LinkGeneric
12/2001 - 11/2000
2Fibrinogen (Factor I)FDA Link
12/2001 - 11/2000
2Cyclin EIBA
10/2001 - 09/2000
2Insulin (Novolin)FDA Link
10/2001 - 01/2001
2CreatinineIBA
08/2001 - 08/2001
2InterleukinsIBA
05/2001 - 01/2000
2Interleukin-12 (IL 12)IBA
01/2000 - 01/2000
2LigandsIBA
01/2000 - 01/2000
1Interleukin-11 (Interleukin 11)IBA
11/2017
1Hemoglobins (Hemoglobin)IBA
12/2016
1PlatinumIBA
12/2016
1AlbuminsIBA
12/2016
1Glycoproteins (Glycoprotein)IBA
12/2014
1Neutralizing AntibodiesIBA
11/2014
1Doxorubicin (Adriamycin)FDA LinkGeneric
06/2014
1Methotrexate (Mexate)FDA LinkGeneric
06/2014
1Cisplatin (Platino)FDA LinkGeneric
06/2014
1Vinblastine (Vinblastine Sulfate)FDA Link
06/2014
1DNA (Deoxyribonucleic Acid)IBA
01/2014
1ReninIBA
01/2014
1AutoantibodiesIBA
07/2010
18-Hydroxy-2'-DeoxyguanosineIBA
06/2009
1plasmin receptorIBA
06/2009
1Dichlorodiphenyldichloroethane (DDD)IBA
06/2009
1Immunoglobulin E (IgE)IBA
06/2009
1MethylprednisoloneFDA LinkGeneric
06/2009
1EpitopesIBA
04/2009
1Peptides (Polypeptides)IBA
04/2009

Therapy/Procedure

7Therapeutics
12/2016 - 01/2000
3Drug Therapy (Chemotherapy)
12/2016 - 03/2002
3Heterologous Transplantation (Xenotransplantation)
12/2014 - 06/2001
3Hepatectomy
11/2001 - 05/2000
2Kidney Transplantation
01/2014 - 12/2001
2Catheters
03/2010 - 12/2001
2Aftercare (After-Treatment)
06/2009 - 03/2002
2Immunotherapy
04/2009 - 01/2000
2Laparotomy
09/2001 - 12/2000
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
06/2001 - 01/2000
1Salvage Therapy
12/2016
1Liver Transplantation
12/2014
1Cystectomy
06/2014
1Neoadjuvant Therapy
06/2014
1Stents
01/2014